3485-62-9|Clidinium Bromide|(1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-hydroxy-2,2-diphenylacetate;bromide|-范德生物科技公司

Clidinium Bromide

NMR下载 COA and HPLC MSDS下载
names：
(1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-hydroxy-2,2-diphenylacetate;bromide
CAS号：
3485-62-9
MDL Number：
MF(分子式)： C22H26BrNO3 MW(分子量)： 432.35
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Clidinium Bromide
英文别名	Clidinium Bromide; Quarzan; Clidinii bromidum; Bromuro de clidinio; clidinium iodide; clidinium iodide, (+-)-isomer; clidinium iodide, 11C-labeled; clidinium iodide, 3H-labeled; clidinium, 1-(methyl-11C)-labeled; clidinium, 11C-labeled; clidinium, 3H-labeled; N-methyl quinuclidinyl benzilate;
CAS号	3485-62-9
SMILES	C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O.[Br-]
Inchi	InChI=1S/C22H26NO3.BrH/c1-23-14-12-17(13-15-23)20(16-23)26-21(24)22(25,18-8-4-2-5-9-18)19-10-6-3-7-11-19;/h2-11,17,20,25H,12-16H2,1H3;1H/q+1;/p-1
InchiKey	GKEGFOKQMZHVOW-UHFFFAOYSA-M
分子式 Formula	C22H26BrNO3
分子量 Molecular Weight	432.35
闪点 FP
熔点 Melting point
沸点 Boiling point
Polarizability极化度
密度 Density
蒸汽压 Vapor Pressure
溶解度Solubility
性状	White to off-white crystalline powder.
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Clidinium Bromide(CAS:3485-62-9):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Clidinium bromide is an anticholinergic drug, specifically a muscarinic antagonist. It may help symptoms of cramping and abdominal/stomach pain by decreasing stomach acid, and slowing the intestines. It is commonly prescribed in combination with chlordiazepoxide using the brand name Librax.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Ashour S, Kattan N. Simultaneous Determination of Clidinium Bromide andChlordiazepoxide in Combined Dosage Forms by High-Performance LiquidChromatography. J Pharm (Cairo). 2013;201

3:417682. doi: 10.1155/2013/417682. Epub2013 Feb 24. PubMed PMID: 26555978; PubMed Central PMCID: PMC4590797.

[3]Pathak A, Rai P, Rajput SJ. Stability-indicating HPLC method for simultaneousdetermination of clidinium bromide and chlordiazepoxide in combined dosage forms.J Chromatogr Sci. 2010 Mar;48(3):235-9. PubMed PMID: 20223092.

[4]Toral MI, Richter P, Lara N, Jaque P, Soto C, Saavedra M. Simultaneousdetermination of chlordiazepoxide and clidinium bromide in pharmaceuticalformulations by derivative spectrophotometry. Int J Pharm. 1999 Oct28;189(1):67-74. PubMed PMID: 10518686.

[5] Vuignier BI, Oderda GM, Gorman RL, Klein-Schwartz W, Watson WA. Effects ofmagnesium citrate and clidinium bromide on the excretion of activated charcoal innormal subjects. DICP. 1989 Jan;23(1):26-9. PubMed PMID: 2718479.

5: Thiébaud G. [The irritable colon. Significance of a combination of clidiniumbromide, chlordiazepoxide and propyphenazone in its therapy]. Schweiz Rundsch MedPrax. 1973 Dec 4;62(49):1521-5. French. PubMed PMID: 4752182.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开